跳至主要内容
临床试验/JPRN-UMIN000024685
JPRN-UMIN000024685招募中3 期

Efficacy of daiobotampito in the treatment of acute diverticulitis of colon: a single-center open-label randomized controlled trial - Trial about efficacy of daiobotampito in the treatment of acute diverticulitis

Gastrointestinal Medcine, Tokyo Saiseikai Central Hospital0 个研究点目标入组 60 人开始时间: 2016年12月1日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • High probability to perforate. Diarrhea or soft stool. Chronic appetite loss, abdominal pain or diarrhea. Too friable. Insulin use. Immuno-compromised host. Pregnant or puerperal. Kidney disease (eGFR < 20 ml/min/1.73m^2). Allergy to daiobotampito. Experience to join in this trial before. Doctor's diagnosis as inappropriate.

研究者

发起方
Gastrointestinal Medcine, Tokyo Saiseikai Central Hospital

相似试验